title: Utilizing selection biomarkers in clinical trials: is this the future of drug development?
authors.affiliation: Amplion, Inc., 1011 SW Emkay Dr., Suite 208, Bend, OR 97702, USA.
authors.forename: Adam
authors.initials: A
authors.lastname: Carroll
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms; D057285:Precision Medicine
chemical_list: D015415:Biomarkers
keywords: LOA; biomarkers; clinical trials; companion diagnostics; drug development; likelihood of approval; oncology; patient selection biomarkers; precision medicine; rare disease